Sinoway Industrial Co., Ltd.

Apixaban 503612-47-3 Apixaban 503612-47-3

Apixaban 503612-47-3
Related Products
  • L-Glutathione Reduced (GSH) 70-18-8

    L-Glutathione ReducedBasic information of L-Glutathione Reduced:Product name: L-Glutathione ReducedMolecular Formula : C20H32N6O12S2Molecular Weight: 612.63CAS No.:70-18-8ENIECE No: 200-725-4Appearanc...

  • Copper Peptide (GHK)2-CU 49557-75-7

    Copper peptide GHK-CuBasic information of copper peptide GHK-Cu :Product Name(GHK)2-Cu(Copper Peptide)SynonymsGHK-Cu (Copper peptide)CAS #49557-75-7Molecular FormulaC28H46N12O8Cu Molecular Weight742.2...

  • Isoflavones in Soy 574-12-9

    Soybean Extract1.Basic information of Soybean Extract:Product name: Soybean ExtractSource: glycine maxUsed part: germ/bean pulpSpec.: total soy isoflavone 40%, 80% by HPLCNameSoybean Extract PowderTyp...

Basic information of Apixaban :

Name

Apixaban

Alias

1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide

CAS NO.

503612-47-3

Molecular Formula

C25H25N5O4

Molecular Weight

459.504

EINECS

1308068-626-2

Brief Introduction

Apixaban is a novel, oral, reversible, highly selective, direct Factor Xa inhibitor developed by Pfizer and Bristol-Myers Squibb.

Storage condition

Room temperature, seal.

Use of Apixaban:

The results of the study show that compared with traditional anticoagulants, Apixaban is more effective and does not increase or decrease the risk of bleeding. Currently, the US FDA and the European EMA have approved Apixaban for prevention of venous thromboembolism (also known as venous thromboembolism or VTE) in adults undergoing total hip or total knee arthroplasty to prevent stroke and systemic embolism in patients with non-valvular atrial fibrillation ( Also known as atrial fibrillation stroke), treatment of deep vein thromboembolism (also known as deep vein thrombosis or DVT) and pulmonary embolism (also known as PE), and prevention of recurrence of DVT and PE.

COA of Apixaban :

Apixaban 503612-47-3


  • Capecitabine 154361-50-9
    Basic information of Capecitabine:NameCapecitabineAlias5'-DEOXY-5-FLUOROCYTISINE;5'-DEOXY-5-FLUORO-N-[(PENTYLOXY)CARBONYL]CYTIDINE;CAPECITABINE;RO-9-1978;pentyl [1-(3,4-dihydroxy-5-methyl-oxolan-2-yl)... Capecitabine 154361-50-9
  • Donepezil 120014-06-4
    Basic information of DonepezilNameDonepezilAlias2-[(1-Benzyl-4-piperidyl)methyl]-5,6-dimethoxy-2,3-dihydroinden-1-oneCAS Number120014-06-4Molecular FormulaC24H29NO3Molecular Weight379.49Quality Standa... Donepezil 120014-06-4
  • Pitavastatin Calcium 147526-32-7
    Basic information of Pitavastatin Calcium :NamePitavastatincalciumCAS :147526-32-7Molecular FormulaC50H46CaF2N2O8Molecular Weight880.98Quality StandardIn-house Standard, Assay: >99.0% Package Size... Pitavastatin Calcium 147526-32-7
  • Sulfadimidine sodium 1981-58-4
    Basic information of Sulfadimidine sodium :NameSulfadimidine sodiumAlias4-AMINO-N-[4,6-DIMETHYL-2-PYRIMIDINYL]BENZENE-SULFONAMIDE SODIUM SALT;SULFADIMIDINE SODIUM;SULFAMETHAZINE SODIUM SALT;(n(sup1)-... Sulfadimidine sodium 1981-58-4

MORE_DETAIL Apixaban 503612-47-3

Basic information of Apixaban :

Name

Apixaban

Alias

1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide

CAS NO.

503612-47-3

Molecular Formula

C25H25N5O4

Molecular Weight

459.504

EINECS

1308068-626-2

Brief Introduction

Apixaban is a novel, oral, reversible, highly selective, direct Factor Xa inhibitor developed by Pfizer and Bristol-Myers Squibb.

Storage condition

Room temperature, seal.

Use of Apixaban:

The results of the study show that compared with traditional anticoagulants, Apixaban is more effective and does not increase or decrease the risk of bleeding. Currently, the US FDA and the European EMA have approved Apixaban for prevention of venous thromboembolism (also known as venous thromboembolism or VTE) in adults undergoing total hip or total knee arthroplasty to prevent stroke and systemic embolism in patients with non-valvular atrial fibrillation ( Also known as atrial fibrillation stroke), treatment of deep vein thromboembolism (also known as deep vein thrombosis or DVT) and pulmonary embolism (also known as PE), and prevention of recurrence of DVT and PE.

COA of Apixaban :

Apixaban 503612-47-3

Leave a Message Email Us

we will contact you within 24 hours.

  • TEL:+86-0592-5854962
  • FAX:+86-0592-5854960
  • EMAIL: xie@china-sinoway.com
  • ADDRESS:Floor 16, Huicheng Business Center, No. 839, Xiahe Rd., Siming Dist. Xiamen, Fujian, China
//